Page 968 - Williams Hematology ( PDFDrive )
P. 968

942  Part VII:  Neutrophils, Eosinophils, Basophils, and Mast Cells  Chapter 61:  Production, Distribution, and Fate of Neutrophils   943




                  postcapillary venules.  This model has been investigated in a variety of   error and relatively poor correlation with kinetics, as measured by other
                                 98
                                                                                 68
                           99
                  vascular beds  and in vitro with monolayers of endothelial cells in par-  techniques.  For example, the morphologic findings in the marrow of a
                  allel plate flow chambers.  The tethering event in this model depends   “maturation arrest,” with little neutrophil development beyond the pro-
                                    98
                  on adhesion molecules in the selectin family, E-selectin and P-selectin   myelocyte or myelocyte stage, does not distinguish between a defect in
                  on the endothelium, L-selectin on the neutrophil, and ligands for the   precursor cell maturation and rapid mobilization of postmitotic cells
                  selectins expressed on both cell types. These adhesion molecules are   from the marrow. Similarly, distinguishing by purely morphologic means
                  necessary to efficiently initiate the cascade of adhesive steps ultimately   neutropenic conditions resulting from ineffective neutrophil produc-
                  leading to firm attachment of the neutrophils to endothelium. The cas-  tion from conditions caused by peripheral destruction of neutrophils
                  cade appears to be necessary for neutrophils to move from blood to   often is difficult. However, despite these limitations, when the absolute
                  tissues because the unstimulated neutrophil is not adhesive to endothe-  neutrophil count and marrow cellularity are used together, they provide
                  lium. 98,100  The integrins necessary for firm adhesion and cell locomotion   a useful guide in most clinical settings. If the absolute neutrophil count
                                                                                      9
                  require stimulation to promote sufficient increases in avidity or affinity   is less than 1.0 × 10 /L and multiple marrow aspirations and/or biopsies
                  to support these functions (Chap. 19).                are hypocellular, the patient almost invariably has impaired production
                                                                        of marrow neutrophils. Very low neutrophil counts predispose to infec-
                  LIFE SPAN OF NEUTROPHILS                              tions by bacteria and certain fungi (e.g., Candida and Aspergillus). Such
                  After emigrating into tissue, the life span of neutrophils can be signifi-  infections become especially troublesome as the neutrophil count falls
                                                                        below 0.5 × 10 /L (Chap. 65). Unfortunately, the converse is not true.
                                                                                   9
                  cantly prolonged (24 to 48 hours).  Programmed cell death (apoptosis)   The finding of cellular marrow and neutrophil count >1.0 × 10 /L does
                                          101
                                                                                                                      9
                  accounts for significant removal of tissue neutrophils through phagocy-  not mean production is normal. Nevertheless, when marrow cellularity
                  tosis by macrophages. The constitutive rate of apoptosis of neutrophils is   and absolute neutrophil count are considered together, they provide the
                  altered by inflammatory cytokines and chemokines. For example, tumor   most clinically useful assessment of neutrophil production.
                  necrosis factor-α (TNF-α) accelerates the rate, but endotoxin, G-CSF,
                  GM-CSF, IL-15, and IL-3 inhibit the rate of apoptosis. The balance of
                  these effects at specific inflammatory sites is poorly understood, but the   FUNCTIONAL EVALUATION
                  functional life of neutrophils in tissue appears to be controlled by the   Several agents that increase neutrophil numbers in circulation,
                  rate of apoptosis. Apoptotic neutrophils lose the ability to release gran-  including glucocorticoids, endotoxin, and etiocholanolone, have
                  ular enzymes in response to external stimuli (see below), and marked   been used to evaluate neutrophil reserves in a clinical setting. These
                  changes in cell surface proteins occur (e.g., CD16, CD43, CD62L are   agents have been supplanted by recombinant human G-CSF, a
                  greatly reduced). Although the loss of responsiveness may contribute to   remarkably nontoxic cytokine that, when given in therapeutic doses
                  resolution of the inflammatory process, evidence indicates macrophages   (5 to 8 mcg/kg), increases the blood neutrophil count by stimulat-
                  also are altered by the phagocytosis of apoptotic neutrophils. In con-  ing neutrophil production and accelerating neutrophil release from
                  trast to the macrophage response to phagocytosis of microbes, where   the marrow storage compartment (Chap. 65). The increase in neu-
                  secretion of proinflammatory cytokines (e.g., IL-1β) and chemokines   trophil production results from a threefold increase in the number
                  (e.g., IL-8) is stimulated, phagocytosis of apoptotic neutrophils fails to   of cell divisions in the mitotic compartment and shortening of the
                  provoke secretion of proinflammatory factors; instead, phagocytosis   maturation time from myelocyte to neutrophil from 4 to 5 days to
                  stimulates release of factors that may suppress inflammatory responses   less than 1 day. 102,103  Thus, as a byproduct of its therapeutic action,
                  (e.g., transforming growth factor-β and prostaglandin E ). Macrophage   G-CSF administration directly tests an individual’s capacity to pro-
                                                          2
                  recognition of apoptotic neutrophils is partially understood to involve   duce neutrophils. This effect of G-CSF makes obsolete most of the
                  the vitronectin receptor α β  and the thrombospondin receptor CD36   older methods for evaluating neutrophil compartments.
                                     V 3
                  on the macrophage surface. In addition, phosphatidylserine residues on   G-CSF does not test the distribution of neutrophils between the
                  the neutrophil are involved. 98                       marginated and circulating pools. On the rare occasions when such
                     Neutrophils are capable of phenotypic changes depending on the   information is desirable, epinephrine stimulation can be used to assess
                  tissue and cytokine/chemokine milieu at the time of their migration   the distribution. For this purpose, epinephrine 0.1 mg infused intra-
                  into tissue (Chap. 60). Because our understanding of neutrophil physi-  venously over 5 minutes has been used, and blood for white counts is
                  ology is relatively new, knowing the extent of this phenomenon on neu-  obtained before and 1, 3, and 5 minutes after completion of the epi-
                  trophil life span in tissues is not possible at present.
                                                                        nephrine infusion. Normally the neutrophils increase by approximately
                                                                        50 percent after epinephrine infusion. 104
                       EVALUATION OF ADEQUACY OF
                     NEUTROPHIL RESERVES                                REFERENCES
                                                                          1.  Kondo M, Wagers AJ, Manz MG, et al: Biology of hematopoietic stem cells and progen-
                                                                           itors: Implications for clinical application. Annu Rev Immunol 21:759, 2003.
                  WHITE CELL COUNT AND MARROW                             2.  Spangrude GJ: When is a stem cell really a stem cell? Bone Marrow Transplant 32 Suppl
                  CELLULARITY                                              1:S7, 2003.
                                                                          3.  Smaaland R, Sothern RB, Laerum OD, Abrahamsen JF: Rhythms in human bone mar-
                  White cell and absolute neutrophil counts are the most widely used   row and blood cells. Chronobiol Int 19:101, 2002.
                  guides to the status of neutrophil production. They are useful in evalu-    4.  Metcalf D: Hematopoietic stem cells: Old and new. Biomed Pharmacother 55:75, 2001.
                  ating the effects of cytotoxic chemotherapy, although they do not pro-    5.  Athens JW: Neutrophilic granulocyte kinetics and granulopoiesis, in  Regulation of
                  vide quantitative information on the rate of neutrophil production or   Hematopoiesis, edited by Gordon AS, p 1143. Appleton-Century-Crofts, New York,
                                                                           1961.
                  destruction, the status of marrow reserves, or the presence of abnormal-    6.  Athens JW, Raab SO, Haab OP, et al: Leukokinetic studies. III. The distribution of gran-
                  ities in cell distribution.                              ulocytes in the blood of normal subjects. J Clin Invest 40:159, 1961.
                     Gauging neutrophil production by the appearance of marrow     7.  Athens JW, Haab OP, Raab SO, et al: Leukokinetic studies. IV. The total blood, circu-
                                                                           lating and marginal granulocyte pools and the granulocyte turnover rate in normal
                  films, clot sections, or biopsies suffers from the limitations of sampling   subjects. J Clin Invest 40:989, 1961.






          Kaushansky_chapter 61_p0939-0946.indd   943                                                                   9/18/15   9:42 AM
   963   964   965   966   967   968   969   970   971   972   973